Copyright © 2015 - 2022 Lifecarenews.in
LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Psyence Group Announces Closing of Fourth Tranche of
TORONTO, April 03, 2023 (GLOBE NEWSWIRE) -- Psyence Group inc.…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Psyence
Psyence Group Completes Export of Pharma Grade Psilocybin
TORONTO, Jan. 20, 2023 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the “Company”) is pleased to announce that it has exported purified pharmaceutical grade psilocybin mushroom extract to its Contract…
Psyence Announces Business Combination between Wholly Owned
VANCOUVER, British Columbia, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE:PSYG | OTCQB: PSYGF), a life science biotechnology company pioneering the use of natural psilocybin in mental health and well-being (“Psyence”), and…
Psyence Signs Letter of Intent with Australian CRO iNGENū
VANCOUVER, British Columbia, Jan. 08, 2023 (GLOBE NEWSWIRE) -- Psyence Group Inc (CSE:PSYG | OTCQB: PSYGF), a life science biotechnology company pioneering the use of natural psilocybin in mental health and well-being, today announced…
Psyence Group Announces Closing of Second Tranche of
TORONTO, Dec. 14, 2022 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the “Company”), a life science biotechnology company pioneering the use of natural psychedelics in mental health and well-being is…